📰 Nasdaq Ards News
Nasdaq Ards News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Ards. Real-time updates on events, politics, business and more.
July 21, 2023
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily trading volume, of 3,360,000 […]
July 21, 2023
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily volume of 3,360,000 shares, […]
June 7, 2023
Aridis Pharmaceuticals (NASDAQ:ARDS – Get Rating) and Satsuma Pharmaceuticals (NASDAQ:STSA – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Aridis Pharmaceuticals and Satsuma Pharmaceuticals’ […]
May 13, 2023
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 404,400 shares, a decrease of 29.5% from the April 15th total of 573,300 shares. Based on an average daily volume of 914,300 shares, the […]
April 26, 2023
LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical...
April 14, 2023
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 571,400 shares, a decline of 81.3% from the March 15th total of 3,060,000 shares. Based on an average trading volume of 1,580,000 shares, the days-to-cover ratio is […]
April 1, 2023
LOS GATOS, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical...
March 27, 2023
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 3,060,000 shares, an increase of 323.8% from the February 28th total of 722,100 shares. Based on an average daily volume of 1,530,000 shares, the […]
May 21, 2022
Wall Street brokerages expect that Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) will report earnings per share of ($0.48) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Aridis Pharmaceuticals’ earnings, with estimates ranging from ($0.49) to ($0.46). Aridis Pharmaceuticals reported earnings per share of ($0.55) in the same quarter last […]
May 1, 2022
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 72,000 shares, a decrease of 36.3% from the March 31st total of 113,000 shares. Based on an average daily volume of 1,380,000 shares, the days-to-cover ratio is […]